Rhaeos, Inc, a clinical stage medical device technology company, is pleased to announce that it has been awarded a $1.5 million grant (Federal Award # 1UG3NS130338) from the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) through its Blueprint MedTech program. This grant will further the development of its FDA breakthrough designated medical technology designed to transform the management of hydrocephalus, a neurological condition affecting ove...
Strategically positioned to accelerate growth and expand presence in key markets across the United States, Europe, and the Asia-Pacific region...
SigTuple’s AI100 with ShonitTM receives U.S. FDA 510(k) Clearance...
AI-assisted ultrasound algorithms will be developed to run on multiple ultrasound devices...
Avasa aims at transforming procedures in reconnecting veins and arteries in reconstructive microsurgery...
The incubator aims to advance healthcare innovations by fostering a thriving ecosystem for biomedtech startups...
JelloX Biotech, a Taiwanese startup, is at the forefront of revolutionising cancer pathology by utilising 3D digital imaging and Artificial Intelligence (AI) technology. Its 3D imaging technology demonstrates potential beyond the field of oncology. In a groundbreaking paper published in February 2023, Dr Lin-Shien Fu and colleagues from Taiwan's Taichung Veterans General Hospital showcased the innovative application of their 3D pathology in analysing kidney inflammation caused by lupus nephritis...
Funding will help with completing a major clinical trial to obtain US FDA approval for the Neonav® ECG Tip Location System...
Accuro XV integrates ultrasound-based bone and 3D soft-tissue imaging technology with AI-enabled software....
eparation enhances Company focus on Pharmaceutical and MedTech Research & Development to deliver innovative and differentiated health outcomes ...
